Joanna Dulinska-Litewka

Prof. Dr. Joanna Dulinska-Litewka

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in Materials
Verified
Journal Article
Open access
PDF file
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
AŁAgnieszka Łazarczyk
Agnieszka Łazarczyk
Przemysław HałubiecPrzemysław Hałubiec
Przemysław Hałubiec
OSOskar Szafrański
Oskar Szafrański
KKKarolina Karnas
Karolina Karnas
AKAnna Karewicz
Anna Karewicz
The recent, fast development of nanotechnology is reflected in the medical sciences. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are an excellent example. Thanks to their superparamagnetic properties, SPIONs have found application in Magnetic Resonance Imaging (MRI) and magnetic hyperthermia. Unlike bulk iron, SPIONs do not have remnant magnetization in the absence of the external magnetic field; therefore, a precise remote control over their action is possible. This makes them also useful as a component of the advanced drug delivery systems. Due to their easy synthesis, biocompatibility, multifunctionality, and possibility of further surface modification with various chemical agents, SPIONs could support many fields of medicine. SPIONs have also some disadvantages, such as their high uptake by macrophages. Nevertheless, based on the ongoing studies, they seem to be very promising in oncological therapy (especially in the brain, breast, prostate, and pancreatic tumors). The main goal of our paper is, therefore, to present the basic properties of SPIONs, to discuss their current role in medicine, and to review their applications in order to inspire future developments of new, improved SPION systems.

31 May 2021 in Nutrition Research Reviews
Verified
Journal Article
Open access
PDF file
TBTorsten Bohn
Torsten Bohn
M. Luisa BonetM. Luisa Bonet
M. Luisa Bonet
PBPatrick Borel
Patrick Borel
JKJaap Keijer
Jaap Keijer
Jean-Francois LandrierJean-Francois Landrier
Jean-Francois Landrier
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
Dietary intake and tissue levels of carotenoids have been associated with a reduced risk of several chronic diseases, including cardiovascular diseases, type 2 diabetes, obesity, brain-related diseases and some types of cancer. However, intervention trials with isolated carotenoid supplements have mostly failed to confirm the postulated health benefits. It has thereby been speculated that dosing, matrix and synergistic effects, as well as underlying health and the individual nutritional status plus genetic background do play a role. It appears that our knowledge on carotenoid-mediated health benefits may still be incomplete, as the underlying mechanisms of action are poorly understood in relation to human relevance. Antioxidant mechanisms – direct or via transcription factors such as NRF2 and NF-κB – and activation of nuclear hormone receptor pathways such as of RAR, RXR or also PPARs, via carotenoid metabolites, are the basic principles which we try to connect with carotenoid-transmitted health benefits as exemplified with described common diseases including obesity/diabetes and cancer. Depending on the targeted diseases, single or multiple mechanisms of actions may play a role. In this review and position paper, we try to highlight our present knowledge on carotenoid metabolism and mechanisms translatable into health benefits related to several chronic diseases.

11 October 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MWMateusz Wylaź
Mateusz Wylaź
AKAnna Kaczmarska
Anna Kaczmarska
DPDawid Pajor
Dawid Pajor
MHMatthew Hryniewicki
Matthew Hryniewicki
DGDorota Gil
Dorota Gil
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
Breast cancer (BC) and prostate cancer (PC) are at the top of the list when it comes to the most common types of cancers worldwide. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway is important, in that it strongly influences the development and progression of these tumors. Previous studies have emphasized the key role of inhibitors of the PIK3/AKT/mTOR signaling pathway in the treatment of BC and PC, and it remains to be a crucial method of treatment. In this review, the inhibitors of these signaling pathways are compared, as well as their effectiveness in therapy and potential as therapeutic agents. The use of these inhibitors as polytherapy is evaluated, especially with the use of hormonal therapy, which has shown promising results.

29 December 2021 in Materials
Verified
Journal Article
Open access
PDF file
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
KDKacper Dykas
Kacper Dykas
DFDominik Felkle
Dominik Felkle
KKKarolina Karnas
Karolina Karnas
Gohar KhachatryanGohar Khachatryan
Gohar Khachatryan
AKAnna Karewicz
Anna Karewicz
For the last years scientific community has witnessed a rapid development of novel types of biomaterials, which properties made them applicable in numerous fields of medicine. Although nanosilver, well-known for its antimicrobial, anti-angiogenic, anti-inflammatory and anticancer activities, as well as hyaluronic acid, a natural polysaccharide playing a vital role in the modulation of tissue repair, signal transduction, angiogenesis, cell motility and cancer metastasis, are both thoroughly described in the literature, their complexes are still a novel topic. In this review we introduce the most recent research about the synthesis, properties, and potential applications of HA-nanosilver composites. We also make an attempt to explain the variety of mechanisms involved in their action. Finally, we present biocompatible and biodegradable complexes with bactericidal activity and low cytotoxicity, which properties suggest their suitability for the prophylaxis and therapy of chronic wounds, as well as analgetic therapies, anticancer strategies and the detection of chemical substances and malignant cells. Cited studies reveal that the usage of hyaluronic acid-silver nanocomposites appears to be efficient and safe in clinical practice.

24 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
WKWojciech Kowalczyk
Wojciech Kowalczyk
GWGrzegorz Waliszczak
Grzegorz Waliszczak
Robert JachRobert Jach
Robert Jach
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
Breast cancer remains one of the most important health problems worldwide. The family of steroid receptors (SRs), which comprise estrogen (ER), progesterone (PR), androgen (AR), glucocorticoid (GR) and mineralocorticoid (MR) receptors, along with a receptor for a secosteroid—vitamin D, play a crucial role in the pathogenesis of the disease. They function predominantly as nuclear receptors to regulate gene expression, however, their full spectrum of action reaches far beyond this basic mechanism. SRs are involved in a vast variety of interactions with other proteins, including extensive crosstalk with each other. How they affect the biology of a breast cell depends on such factors as post-translational modifications, expression of coregulators, or which SR isoform is predominantly synthesized in a given cellular context. Although ER has been successfully utilized as a breast cancer therapy target for years, research on therapeutic application of other SRs is still ongoing. Designing effective hormone therapies requires thorough understanding of the molecular function of the SRs. Over the past decades, huge amount of data was obtained in multiple studies exploring this field, therefore in this review we attempt to summarize the current knowledge in a comprehensive way.

10 April 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
JDJoanna Dulinska-Litewka
Joanna Dulinska-Litewka
Yoav SharoniYoav Sharoni
Yoav Sharoni
Przemysław HałubiecPrzemysław Hałubiec
Przemysław Hałubiec
AŁAgnieszka Łazarczyk
Agnieszka Łazarczyk
OSOskar Szafrański
Oskar Szafrański
TBTorsten Bohn
Torsten Bohn
Among the vast variety of plant-derived phytochemicals, the group of carotenoids has continuously been investigated in order to optimize their potential application in the area of dietary intervention and medicine. One organ which has been especially targeted in many of these studies and clinical trials is the human prostate. Without doubt, carotenoids (and their endogenous derivatives—retinoids and other apo-carotenoids) are involved in intra- and intercellular signaling, cell growth and differentiation of prostate tissue. Due to the accumulation of new data on the role of different carotenoids such as lycopene (LC) and β-carotene (BC) in prostatic physiology and pathology, the present review aims to cover the past ten years of research in this area. Data from experimental studies are presented in the first part of the review, while epidemiological studies are disclosed and discussed in the second part. The objective of this compilation is to emphasize the present state of knowledge regarding the most potent molecular targets of carotenoids and their main metabolites, as well as to propose promising carotenoid agents for the prevention and treatment of prostatic diseases.